Tremfya 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FP1VE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,772
Award facts
- Contract value 100% obligated
- $37,772.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $37,772.17 delivery order to AmerSourceBergen Drug Corp for TREMFYA 100 mg/mL syringes on February 4, 2026, with an ultimate completion date of February 5, 2026. This competitively awarded, firm fixed-price contract was placed without a set-aside designation and is being performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a prescription biologic medication used for the treatment of psoriasis and other immune-mediated inflammatory conditions, representing a specialized pharmaceutical supply requirement for military healthcare systems.
This delivery order falls under AmerSourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This primary vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerSourceBergen's status as a critical federal pharmaceutical vendor is demonstrated through its extensive contract portfolio with DLA and other federal agencies supporting military treatment facilities, veterans' healthcare programs, and other government medical institutions.
Quick answers
Who was awarded contract SPE2DR26FP1VE?
SPE2DR26FP1VE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FP1VE worth?
The government has obligated $37,772 on SPE2DR26FP1VE.
Is contract SPE2DR26FP1VE an order under another contract?
Yes. SPE2DR26FP1VE is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1VE competed?
The extent of competition for SPE2DR26FP1VE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award